Good morning.
Futures pointing lower after the worst tape in months. S&P flat Friday but -2% on the week. Nasdaq -4%, five straight down days. SOXX -5%+ weekly, with memory stocks getting crushed Friday despite MU’s monster print. Asia cratered overnight: Kospi -5.8%, Nikkei -4.1%, SoftBank -12%. That’s the macro pushback real — Kashkari explicitly saying AI capex is pushing up rates.
MU blew out Q3 — $41.5B revenue, $28B net income, guide $50B+ — but the stock reversed from +16% to -4.5% by Friday close. A multi-billion sell order hit within 30 minutes of the open. Not a fundamental rejection, but tells you positioning is max long and any tape weakness triggers violent de-grossing. NVDA’s NVFP4 quantization is also eating the memory footprint per model (~69% reduction), adding a secular volume risk to the HBM bull case.
ON agreed to buy SYNA in an all-stock deal, ON -19% intraday. Market hates it — distraction from AI data center silicon, dilution. SYNA barely up, which tells you the premium wasn’t enough.
Three themes framing the day:
1. AI Capex Fatigue vs. Structural Demand. The market is wrestling with whether $1T+ in AI infrastructure creates an inflationary credit impulse that kills the very demand it’s meant to serve. This is the macro overhang on every semi name. Hyperscalers with software ecosystems (MSFT, AMZN) are better insulated than pure-play compute.
2. Memory Cycle Peak Anxiety. MU’s guide was stellar — supply tight through 2028 — but investors are asking “what’s the rate of change from here?” With NVDA compressing memory needs via software and hyperscalers reportedly colluding to push DRAM prices down, the marginal buyer is less convinced.
3. Passive Component Bottleneck. MLCC book-to-bill above 1.0 at Murata, SEMCO, Taiyo Yuden going into 2Q26. Structural shortage expected Q4 2026. That’s a real distribution constraint on AI rack builds — watch AVGO and NVDA supply chain comments.
We’ll hit up MU, AVGO, and ON first, then get to memory and semi cap equipment names.
THE ON–SYNAPTICS DEAL IS A STRATEGIC BET THAT SPLITS THE STREET. The $7B all-stock acquisition of SYNA gets ON into edge AI compute, connectivity, and sensors — but at the cost of narrative simplicity. The stock's already up 121% YTD, and the analyst reaction is a Rorschach test: bulls see a TAM expansion to $243B by 2030, bears see a messy integration into consumer/wireless exposure (60% of SYNA sales). PT range runs $100 (Cantor) to $150 (Mizuho), with the consensus clustering around $107-$130. Not a ringing endorsement.
What's new vs. what we knew. The acquisition itself is new (announced yesterday). ON pays a fixed ratio of 1.35x shares, valuing SYNA at ~27x 2027 P/E — in line with ON's own multiple. Management expects $200M in synergies (85-90% OpEx), accretion within 18 months of closing (mid-2027 target), and an analyst day on September 26. What we already knew: ON's auto/industrial exposure, the massive YTD rally, and the general thesis that physical AI is a multi-year secular trend. The deal accelerates that thesis but adds integration risk.
The consensus on the deal itself: It's incremental positive for long-term strategy. The portfolio gap (lack of MCU/SoC processing) gets filled. The question is how much synergy upside is real vs. aspirational.
The Bull Case (Needham, Mizuho): This is a TAM expansion story. The $243B addressable market by 2030 is the headline — power, sensing, control, connected compute all under one roof. Minimal product overlap. The $200M synergy target is achievable given redundant functions. At 24x 2028 EPS of $5.50 (Needham), the stock isn't pricing in the full accretion runway. Mizuho's $150 target implies ~27x their pro forma 2026 EPS of $3.21 — a premium to SOX at 24x, but justified by the AI/edge pivot. The bull argument: ON is transforming from a cyclical semi play into a physical AI compounder, and the market hasn't fully repriced that yet.
"The acquisition expands ON's addressable market to include edge and physical AI. Little product overlap. Complementary revenue with $200M of annual synergies." - Needham
The Bear Case (TD Cowen, Stifel, Cantor): This muddies the narrative. ON's earnings model was already reliant on "loadings" (utilization/capacity) to drive EPS — now you're adding a consumer/wireless-heavy business (60% of SYNA sales) that's inherently lumpy. TD Cowen's downgrade to Hold is blunt: "fairly valued at ~25x 2027 estimates" after the 100%+ YTD run. Cantor flags the "magnitude and timing" of revenue synergies as the open question — management is confident, but there's no track record. Stifel's $107 target sits below the current price of $118.74, implying the stock has run ahead of fundamentals. The bear case: this is a complex integration in an already complex macro (auto slowdown, China uncertainty), and the niche NPU processors SYNA brings aren't a credible beachhead against diversified players.
"The deal adds complexity to a model reliant on loadings to drive EPS. SYNA's consumer/wireless exposure (60% of sales) muddies the narrative despite its growing edge AI business... shares are fairly valued at ~25x 2027 estimates." - TD Cowen
This is a story stock now, for better or worse. The bull/bear debate isn't about Q2 numbers — it's about whether ON can execute a transformational M&A while the core business faces cyclical headwinds. The stock's 121% YTD rally has already priced in some good news. The near-term catalyst is September's analyst day, where we'll get concrete synergy targets and the combined roadshow. Read-through to peers: This validates the "physical AI" thematic across semi-land — expect more deals in sensing/connectivity/compute. But it also highlights the premium the market assigns to AI-exposed names vs. traditional auto/industrial semi players. Watch for moves in STM, NXPI, and even MRVL (edge compute overlap).
Verdict: The bull case is real if you have a 2-3 year time horizon and believe in management's ability to integrate. The bear case is equally valid if you think the stock's already there and the deal adds complexity without immediate EPS acceleration. For a multi-manager book, this is a position-sizing call based on your conviction in the "physical AI" secular thesis vs. near-term execution risk. We're at 25x forward estimates, the deal is not accretive until mid-2027, and the stock is up 121% YTD. That's a narrow path to alpha.
Verdict: Neutral-to-bearish signal cluster forming, but the bull case isn’t dead — it’s just hiding in iPhone 18. The intra-cycle price hike is the tell.
Apple did something it rarely does — raised prices mid-cycle on Macs, iPads, and Apple TV (+17% to +25% on base configs, Apple TV up 54%). Evercore ISI (Outperform, PT $365) reads this as a direct response to DRAM/NAND costs now “multiples higher” than a year ago. Their key line:
“The intra-cycle price hike suggests the magnitude and pace of cost pressure exceeded Apple’s ability to absorb it.”
UBS (Neutral, PT $296) agrees on the margin math — product gross margins should dip to 36.4% in June and 35.9% in September before hikes kick in. But they don’t think this changes the near-term outlook. iPhones were spared. The real margin test comes with iPhone 18 Pro pricing in September.
UBS also dropped a second note on China — iPhone sell-in declined ~19% YoY in May (CAICT data). Apple’s share in China fell to ~11% from 16% a year ago. That’s a real headwind for a stock trading at 33.7x P/E. June is seasonally small for iPhone, so not a panic trigger. But it does make the bull case harder to push without a strong iPhone 18 cycle.
Bull (Evercore ISI, BofA): Pricing power intact. Margin protection through hikes + iPhone 18 repricing this fall. Memory costs are cyclical — they’ll moderate. AAPL at $279 offers 31% upside to Evercore’s $365 target. The iPhone cycle is still the main event.
Bear (UBS): China share erosion is structural, not just tariff noise. Intra-cycle price hikes risk demand friction in Mac/iPad. Without iPhone price confirmation (or a new category), the margin story is just a pass-through. Current stock is at UBS’s $296 target — r/r balanced at best.
The China data and the price hike together create a narrative tension: cost push = margin protection, volume pull = demand risk. If iPhone 18 pricing is aggressive (+$100, per BofA), the bull case holds. If not, product margins keep sagging into year-end. Neither side gets a clean knockout yet — but the rate of change on these signals is negative for now.
Verdict: The Investor Day reset the narrative. QCOM finally gave the street something to anchor on beyond handsets. Data center targets are aggressive but the market is buying the vision — PTs flooding in from $190-$300 range. Stock at $197 still pricing in skepticism. That's the opportunity if they execute.
Investor Day was a turning point. QCOM laid out a DC revenue ramp from $5B in FY27 to $15B in FY29 — and a total non-handset QCT rev target of $40B by FY29 (vs prior $22B). That's a 40% CAGR. QTL margins held at 70%, QCT at 30%. EPS target above $18 vs consensus $14.55.
The valuation disconnect is stark. Rosenblatt flags QCOM trading at 3.5x FY29 EV/Sales vs peers at 6-11x, and 11x FY29 P/E vs peers at 20-30x. That's the bull case in one sentence.
At least 8 firms revised PTs post-ID. UBS raised to $235 (Neutral), Rosenblatt to $265 (Buy), Benchmark to $300 (Buy), Cantor to $220 (Neutral), Susquehanna to $190, Morgan Stanley upgraded to Equalweight at $231. The cluster is $190-$300, with the median around $235-265.
UBS (Neutral) still cautious: they see most of the revenue upside from DC, but edge TAM >$1T is "lucrative" — they just need to see it materialize. Rosenblatt is all-in on the valuation gap:
"The stock trades at 3.5 times fiscal 2029 enterprise value to sales versus peers at 6 to 11 times, and 11 times fiscal 2029 price-to-earnings versus peers at 20 to 30 times."
That's a 50-60% discount to semi peers on 3-year forward numbers.
Bull: QCOM is finally shedding the Apple overhang and handset gravity. DC server CPU + AI accelerators open a $175B TAM. If they hit even half the $15B target, the multiple re-rates. Edge computing is another $1T+ long-tail. At ~21x trailing P/E, this is a growth story priced like a value stock.
Bear: DC is a graveyard for semi companies trying to take share from Intel/AMD/Nvidia. QCOM's Arm-based server CPU is unproven at scale. $15B by FY29 is aspirational, not baked. Handset still drives 70% of revenue — any smartphone cycle hiccup and the narrative breaks. Neutral rating from UBS says it all: "show me."
Stock at $197, ~$208B market cap. The risk/reward tilts positive if you believe the DC ramp is real. But PMs should watch execution — QCOM has to deliver on those FY27 guideposts before the multiple expands. Right now it's a story stock with a valuation floor and a narrative ceiling.
Verdict: Battleground stock trading at distressed multiples. The restructuring (7% RIF, CPO departure) creates near-term uncertainty, but Piper’s meeting with mgmt leaves them confident on bookings momentum. At ~10x CY27 FCF with 76% gross margins and net cash, the downside is protected IF they can execute the path back to 20% growth. The cloud revenue miss last quarter (Q4 cloud $217.4M, -$1.1M QoQ, growth decel to 20% vs 21% expected) is the headline risk. Consensus PTs slashed to $55-$85, but Rosenblatt and Piper both stayed Buy/Overweight. This is a r/r trade: you're betting mgmt's reorg works and growth reaccelerates. Not for the faint-hearted.
Two firms — Piper Sandler (OW, $85) and Rosenblatt (Buy, cut to $83 from $90) — both met with mgmt or cited the restructuring. Both kept positive ratings despite the messy quarter. The collective thesis: Elastic is intentionally burning short-term cloud revenue to reposition for AI-driven growth. The RIF (7%) is about flattening org structure and reallocating headcount to field sales. Mgmt still expects net headcount growth in FY27. Piper came away confident the recent bookings momentum sustains the path back to 20% growth. Rosenblatt acknowledges "increased execution uncertainty over the next few quarters" but sees the current price as pricing in too much pessimism.
Key numbers: ESTC at $53.60, ~$5.6B market cap, ~10x CY27 estimated FCF. Net cash positive. 76% gross margins.
Bull case (Piper & Rosenblatt): Valuation is a gift for a 20% grower with sticky enterprise platform. The restructuring is a proactive realignment — not a distress signal. If cloud revenue stabilizes and AI use cases (search, observability, security) drive incremental spend, the stock has 60% upside to PTs.
Bear case (the Street's price target cuts): Cloud revenue decelerated and declined sequentially for the first time in a Q4 — never a good look. Restructuring creates internal distraction for 2-3 quarters. CPO departure adds product strategy risk. Consensus estimates have been revised down 21 times. Execution is not guaranteed.
"Piper Sandler expressed confidence in Elastic’s ability to sustain recent bookings momentum. The firm believes this momentum should help the company execute on its path back to 20% growth." — Piper Sandler, after mgmt meetings with CEO & CFO.
Bottom line: ESTC is a high-conviction turnaround story trading at cheap multiples — but it requires patience and a bet on mgmt's ability to navigate a choppy transition. PMs looking for distressed value with a catalyst should tilt bull. Those who fear execution risk will stay on sidelines until cloud revenue inflects.
Verdict: Execution machine, but the multiple is doing heavy lifting. PANW +59% YTD is pricing in perfection — and they're delivering it. Revenue beat by 2% (vs. prior April quarter beats of 0.4%/0.6%), NGS ARR beat by 1.9%, and FCF crushed by 22.8% — the strongest beat in two years. Portfolio managers should own the name, but don't expect another 59% from here.
Five firms raised or maintained targets in the $290-345 range (Loop $290, FBN $330, Cantor $340, Piper $345). The collective thesis: PANW is monetizing AI/observability better than anyone in cybersecurity, the cross-sell from CyberArk is accelerating, and FCF conversion inflects hard over the next 2 years. William Blair bumped FY26 FCF estimate to $4.225B — basically signaling confidence in the margin story.
Bull: This is a platform compounding at 20%+ revenue growth with FCF margins heading to 40%. The AI lab relationship (Chronosphere) proves they can land whales on consumption models. Pulling forward CyberArk synergies suggests execution risk is lower than feared.
Bear: 59% YTD gains already price in the FCF inflection and AI tailwinds. At ~$239B market cap, the forward P/FCF multiple is not cheap. The "frontier AI lab" concentration in Chronosphere (single customer >$200M ARR) could flip from validation to concentration risk overnight. Revenue beats are still only 2% — that's not a blowout.
Bottom line: PANW is a core hold, not a fresh buy at these levels. Watch the Q4 print for incremental NNARR acceleration and any signs of AI lab customer churn.
Verdict: Memory cycle is structurally different this time — and the Street is finally pricing it in. The print was a blowout, the guide was a moonshot, and analysts are racing to figure out where the ceiling is. Consensus is coalescing around one idea: this isn't your father's DRAM cycle.
May quarter crushed: $41.5B revenue vs $35.7B consensus, EPS of $25.11 vs $20.49. August guide is even more absurd — $50B rev / $31 EPS vs $43.2B / $25.31. Gross margins exploding to ~85% (reported) with Rosenblatt expecting 86%. That's semiconductor-unicorn territory.
13+ analysts raised PTs post-print. The new cluster: $1,375 (Mizuho) to $2,000 (DA Davidson). Prior range was $1,200-$1,500. The average now sits somewhere around +50% from current $1,048. Consensus is Buy.
Two structural shifts, per Rosenblatt:
1. Capacity additions take longer and are smaller relative to existing base — no repeat of 2018's overshoot. 2. AI workloads demand complex, non-commodity memory (HBM, high-bandwidth) with higher cost per bit and stickier pricing.
The proof is in 16 Strategic Customer Agreements with five-year terms, floor-and-ceiling pricing, and take-or-pay structures. These aren't spot-market handshake deals — they're insurance policies against undersupply.
"These agreements point to a different memory cycle than previous periods." — Rosenblatt
DA Davidson chimes in: PEG ratio of 0.12 (P/E 49x on current, but growth is that fast) makes the stock cheap on a forward basis. Their $2,000 PT is based on 20x CY26 EPS.
Bull case: Structural change. AI demand is secular. Supply growth capped by fab build-out lead times and capital intensity. Margins stay elevated through 2027+. MU is becoming a quasi-utility for hyperscalers.
Bear case: History says memory cycles always revert. 2027 new wafer supply could flood the market. 85% gross margins are unsustainable — mean reversion will crush EPS. The stock already up 725% in one year.
Everyone is converging on supply tight through at least CY27. Even the bears struggle to argue a near-term peak when customers are locking in five-year take-or-pay contracts. The debate is shifting from if the cycle ends to when — and the data says not for another 18-24 months.
Bottom line: MU is pricing in a structural re-rating of the memory industry. The numbers support it. Don't fight the tape — but watch the 2027 capacity timeline like a hawk.
Verdict: SNX keeps printing. Two analyst bumps this morning — UBS to $352, RBC to $340 — after a Q2 that obliterated numbers. 33% billings growth, 62% EPS growth, and the Hyve segment doing +117%. This isn't just a beat, it's a regime change in how the street thinks about distribution. AI is pulling everything.
Q2 non-GAAP EPS of $4.85 vs consensus $4.11 — a 18% beat. Revenue $19.6B versus $16.79B expected. Gross billing growth 33% year-on-year. The fly in the ointment: gross margin of 6.84% missed UBS's 7.18% estimate by 33bps on mix shift (Hyve is lower margin, but higher growth). Operating margin held at 3.14%, right inline. That's the tension — top-line momentum from AI infrastructure is real, but margin quality is getting diluted.
Both UBS and RBC converged on the same thesis: broad-based demand, distribution share gains, and Hyve as an accelerating growth engine. UBS lifted multi-year estimates. RBC highlighted that Hyve's share gain is "a shift toward a more profitable company" — even if gross margin is temporarily lower, the mix of business becomes more durable.
"Hyve's ability to capture market share and expand its contribution to TD Synnex's mix represents a shift toward a more profitable company." — RBC Capital
Bull case: SNX is the plug for AI infrastructure buildout — hyperscale, enterprise data center modernization, and AI-capable devices. The PEG ratio sits at 0.31 — absurdly cheap for a company growing EPS 62% in a quarter. Distribution is consolidating, SNX is taking share, and the scale advantage widens every cycle. The stock is up 105% in 12 months and still at a low P/E relative to growth.
Bear case: Gross margin compression from mix is not a one-quarter thing — Hyve is structurally lower margin. Rising component costs and ASP inflation mess with predictability. If AI capex slows or becomes more concentrated among a few hyperscalers, SNX's leverage drops. The stock already reflects a lot of good news.
Two firms raising to $340-352 from a $310-315 prior cluster. That's a clean step function. Stock currently ~$320-330 range (not given, but context from price action). The 105% YTD run suggests a lot is priced in, but the earnings revision cycle is still early — analysts are still catching up to the EPS trajectory. The key variable: can gross margin stabilize as Hyve scales and operating leverage kicks in on higher volumes? That's the debate for the next 6 months. For now, rate of change favors longs.
This is a show-me story now. Stock prints $111.50 after the investor day, which is down from the ~$115 level where it traded into the event. The narrative is bifurcated: the bulls see a credible multi-year roadmap with a fat buyback; the bears see peak-cycle execution risk and OEM insourcing overhang.
Market Action: VC down ~3% from pre-ID high. The 18% YTD gain is getting tested.
RBC stays Outperform, bumps PT to $130 (from $117). They attended the investor day and came away thinking the long-term guidance is "reasonable." They flag the negative price action as maybe a "sell the news" event (high expectations baked in) plus the structural fear that OEMs take cockpit domain controllers in-house. Upside drivers: more HPC business wins + Chinese OEM exports into Europe.
Baird downgrades to Neutral (from Outperform), PT $121. They're locking in gains after the YTD run. Their concern is math-driven: the new targets need significant new program ramps to offset $650M in expected roll-offs. Plus multiple operating improvement levers need to work while memory prices ramp in 2027.
The broader Street is mixed but tilting constructive: Barclays and JPM both upgraded (Overweight, PTs $145 and $165). Baird is the key dissenter.
Bull case: The $800M buyback (through 2029) is a massive floor. Edge AI launch with Qualcomm (D6Sigma) opens a non-auto TAM. HPC wins + China export momentum provide real revenue growth vector. FCF conversion improving.
Bear case: $650M of program roll-offs are a concrete headwind. Baird isn't wrong that the targets require everything to go right. And the OEM insourcing risk is real — cockpit domain controllers are the crown jewels and automakers want that software stack. Memory tailwinds reverse in 2027.
"The negative share price reaction could reflect high expectations heading into the event and potential for other original equipment manufacturers to insource cockpit domain controllers."
That's the whole debate in one sentence.
Positioning: This is a r/r call, not a fundamental blowup. At $111, you're getting a ~2.7x EV/sales multiple on a company buying back ~27% of its float. But the execution path is narrow. Not a PM position size unless you have edge on the roll-off vs. ramp trajectory.
Verdict: Cantor staying long at $95, and the Q1 print backs them up. Revenue beat by 5.7%, net new ARR of $103M crushed the $85.5M bogey, and management raised FY27 sub-ARR guidance at roughly 2x the Q1 beat. The operating leverage story is starting to show: SBC flat YoY at ~$73M while FCF more than doubled — SBC-to-FCF compressed from 2x to ~1x. That’s the kind of rate-of-change PMs actually care about.
Bull case: RBRK is executing on the land-and-expand playbook. The Identity angle opens a new TAM (CISO budgets), the Flex licensing model (launched at Analyst Day) should drive attach rates, and the FCF inflection is real. $95 target implies ~34% upside from $71 — not a stretch if subscription gross margins hold in the 80%+ range.
Bear counter: SBC is still $73M/quarter. The free cash flow "doubling" was from a low base. And the stock is pricing in perfection on the Identity ramp — any deceleration there and the multiple contracts fast. DA Davidson and Truist both sit at $90, not $95 — so upside conviction isn't universal.
Skinny treatment for a light-coverage ticker. Keep an eye on next quarter's net new ARR vs the raised guide.
Cantor stays Neutral at $110 while the stock trades at $150 — that's a 27% gap. Massive Q1 beats (revenue +6.7%, billings +14.6%) and a 41% surge in product revenue are getting ignored by the rating. Management raised FY26 revenue growth to ~15% and billings to ~18%. The AI data center story is real: multiple seven-figure wins, including a GPU cloud provider and a genAI shop in the Middle East building reference architectures for repeat deployments.
AI agent identity traffic is generating incremental east-west traffic inside enterprise networks, requiring additional internal segmentation that plays to FortiGate's ASIC performance advantage.
The bull case writes itself — record beats, upgraded guidance, 80% gross margins, and 38 analyst revisions higher. But the stock is up 89% YTD and touching fresh highs at $150. Cantor sees limited r/r from here (hence Neutral). The market clearly disagrees, pricing in continued acceleration. For PMs: the fundamental momentum is unquestionable, but the entry point is the whole debate. Wait for a pullback or chase the AI tail? At these levels, the bar is high for another beat of similar magnitude.
Verdict: The ON Semi deal caps SYNA's upside here. TD Cowen downgraded to Hold from Buy, PT stuck at $150 (basically the deal value at ON’s current price of $110/share – 1.35x exchange ratio = ~$149). Stock trades at $125.62, a ~19% discount to that implied value. That spread is the only near-term catalyst. No fundamental thesis left to play.
The acquisition values SYNA at ~$6.5B enterprise value (including $430M net debt). Both boards approved, close expected mid-2027 pending shareholder and regulatory approvals. China exposure is ~10% (mostly Mobile via OVX, some IoT/auto) – not a deal-breaker, but a cross-border review flag.
"TD Cowen maintains a Hold rating on ON Semiconductor with a price target of $118.74."
That PT on the acquirer is ~8% above ON’s current price, so the spread could narrow if ON rallies. But SYNA shares are now a stub – you’re effectively long ON with a discount. Not a great r/r for a multi-manager unless you want to pair it with a short.
Bull case? Only if ON stock rips. SYNA’s standalone beat (FQ3 EPS $1.09 vs $1.01, revs $294M vs $290M) and edge AI partnerships (Accton) are irrelevant now – the deal defines the path. Bear case? Regulatory delay or a hit to ON’s stock (semi cycle, tariffs) widens the discount, but downside is capped at deal break risk. Not a high-conviction long or short. Pass.
Lake Street goes long. Initiating with a Buy and $58 target ($150M balance sheet boost via JV monetization, AI data center pivot). Their thesis: March quarter was THE BOTTOM for rev and gross margins, and the $150M cash injection from the Chongqing JV sale is funding an R&D ramp that should reaccelerate growth. Trade at a material discount to power semi peers.
The miss on EPS (-$0.28 vs -$0.13 consensus) is noise. The revenue beat (+6.7% vs $153.5M) plus the new digital multiphase controller line for Intel Panther Lake / Wildcat Lake are the real signals. Lake Street sees a clean r/r setup.
"We believe the March quarter marked the bottom for both revenue and gross margins at the company… the $150 million monetization of the Chongqing joint venture stake funds an accelerating R&D roadmap for growth."
KeyBanc reiterates Overweight with $41 target post Beyond conference – but the stock sits at $28.98, 43% below the Street high of $57.60. That gap is the call. The thesis: Samsara’s new Tracking Label (single-use Bluetooth asset tag) materially expands TAM beyond traditional connected cameras/sensors, and a fresh go-to-market push is designed to accelerate multi-product attach. Strong fundamentals intact – 76% gross margin, 30% rev growth – but the market is pricing in execution risk on the pull-through.
"The Tracking Label represents meaningful total addressable market expansion." — KeyBanc
Other shops piled in: Wolfe maintained Outperform/$50, Piper Sandler raised to $40 (calling out raised guidance), RBC lifted to $42 (highlighting 30% ARR growth from large customers). Consensus is bullish – the question is whether the stock re-rates as the product cycle proves out. Physical operations software is an attractive vertical, and Samsara remains a high-conviction idea for KeyBanc. Worth watching the next few prints for evidence of Tracking Label adoption velocity.
CRWD keeps printing. Cantor reiterates Overweight with a $725 PT (stock at $678.65, up 45% YTD). The quarter was clean: revenue beat by 1.7% (reversing the prior quarter's 0.1% miss), 23% growth with 75% gross margins, and net new ARR of $256M beat by ~$3M. The real signal is the FY27 guidance raise — management added $52M to midpoint NNARR guidance, citing a RECORD 2Q PIPELINE and accelerating AI-driven demand.
Module adoption continues to deepen — 51% on 6+, 35% on 7+, 25% on 8+. Next-Gen SIEM hit $600M+ ARR, and the combined emerging product suite (Cloud, Next-Gen Identity, SIEM) crossed $2B in ending ARR with record 1Q net new from that group. AIDR (AI Detection & Response) is still tiny but grew 250%+ QoQ, with management flagging a >$50M pipeline for 2Q.
"Management raised fiscal 2027 net new annual recurring revenue guidance by approximately $52 million at the midpoint, citing a record second-quarter pipeline and accelerating AI-driven demand."
Piper Sandler also chimed in with an Overweight and $750 PT, pointing to demand tailwinds from Mythos and Project Glasswing. The stock has ripped 41% in six months, and 27 analysts just revised earnings up. At ~8x forward revenue, it's not cheap, but the AI-cyber narrative is still gaining steam, not peaking. The question for PMs: is the multi-product attach rate already priced in, or do the pipeline comments imply another leg? I lean the latter given the accelerating beat cadence and AI-driven greenfield.
Mixed signals — revenue beat and AI pipeline hype vs. a valuation-driven downgrade. The stock isn't cheap at ~$119, but the narrative clock is ticking faster than the numbers.
Revenue beat consensus by 1.7% (accelerating from 1.1% last Q). cRPO grew 12% YoY — in line with prior quarter but ahead of whisper. Gross margins held at 77%. Customers with >$100k ACV up 6% to 5,180, now 85% of total ACV. New products (Identity Governance, AI agents) booked ~25% of Q1 bookings, but the AI agent line items themselves contributed "not materially" — only modestly embedded in guidance. Management called the AI agent pipeline "larger than anything previously seen" and hinted the timeline is pulling forward.
Cantor reiterated Overweight ($125 PT), arguing the stock looks undervalued post-print. DA Davidson bumped to $130 but stayed Neutral. UBS went to $150 on early AI adoption feedback. Mizuho downgraded to Neutral from Outperform — not on fundamentals, but on price. The bull story is AI agent acceleration (identity for AI agents, Auth0 for AI agents). The bear case: the current business is solid but mature, and the stock already bakes in a lot of future goodness.
"Commentary on the earnings call suggests the opportunity may be developing faster than the prior fiscal 2028 and fiscal 2029 timeline implied." — Cantor Fitzgerald
That's the rate-of-change signal. If AI identity becomes a real revenue driver in FY27-28 instead of FY29+, multiples expand. For now, it's a call on narrative velocity — not current P&L — and the stock needs the pipeline to convert.
Monness upgrades to Buy. Finally a value call on the 45% YTD loser (down 62% from early-2024 peak). Thesis: valuation is washed out, and the underlying business — 76% gross margins, 10% FCF yield, growing agentic AI pipeline — doesn't justify the pain. PT $150, ~27% upside from $118.
"Workday is the worst performing stock in its coverage universe in 2026."
Worth noting: Cantor (OW/$160) and Oppenheimer (Outperform/$165) have been carrying the flag at higher levels. Monness is late to the party but early enough if the AI narrative turns. The AI-hiring discrimination lawsuit is a sidelight — not the driver here.
Verdict: M&A is the right move but Piper stays on the sideline. ADBE at $193 – basically hugging its 52-WEEK LOW OF $190.12 – despite a grotesque 89.4% gross margin and a P/E of just 11.15x. The Topaz Labs acquisition brings AI video/image enhancement plus their Neurostream on-device inference tech into Firefly and Creative Cloud. Smart strategy in a “fierce” competitive environment. But Piper keeps its Neutral / $240 PT because execution risk from the freemium pivot and leadership churn is still real. Don’t confuse cheap with catalyst.
“Competitive environment has gotten increasingly fierce in the AI and agentic era. Pursuing M&A is the right strategy for Adobe.” — Piper Sandler (Neutral, $240 PT)
Bottom line: cheap multiple reflects genuine uncertainty around how (and when) AI features convert to revenue. The Topaz bolt-on is logical but doesn’t change the narrative yet.
$78.80, up 82% over the past year — and the tape is starting to believe it can hold that. Cantor stays Overweight at $80 (in-line with the print), but the real signal is in the acceleration. Cloud revenue hit 50% YoY growth, up from 42% last Q, and management just lifted the FY baseline cloud guide to 33-35% from 30-32%. That’s a conservative layup if the same methodology holds — they delivered 45% on an initial 31% guide last year.
Multiple firms raised PTs to the $80-100 range (Benchmark initiated Buy, UBS to $92, TD Cowen to $100) on AI tailwinds and supply chain security demand. The LiteLLM, Axios, and Shai-Hulud attacks are driving real flow into JFrog Curation — acting as a centralized policy firewall between public repos and internal environments.
“Management noted that none of the security wins in fiscal 2025 were driven by static code analysis, reinforcing that JFrog’s security traction is not overlapping with AI code security tools.”
That’s the key nuance — JFrog isn’t competing with Snyk or GitHub code scanning here. It’s a different vector, and the attach rates are climbing without cannibalization. Cloud margins are pristine (77% gross). Billings +24%, RPO +36%. The bull case is sticky platform expansion; the bear case is that at 82% Y/Y run, multiple expansion is already priced. But for a $2.4B market cap with accelerating top-line and security tailwinds, r/r still favors the owners.
Verdict: BMO stays constructive on data center strategy but the signal is muddy — CFO transition + rate case filing create real short-term noise. Hosted a breakfast with CEO/CFO/IR and came away bullish on the 2H catalysts, specifically management getting more direct on NorthStar and data center load contracting. Stock at $77.10 vs BMO's $81 PT — not screaming value, but the 19-year dividend streak buys patience.
"Management could more directly address industry reports of the potential disposition of NorthStar assets and underscore confidence in their data center strategy at that time." — BMO on the upcoming Q2 call (July 23)
The broader analyst grid is split: KeyBanc Overweight $83, Jefferies downgraded to Hold $74 on CFO change. BMO trimmed PT to $81 after the $456M rate case filing by subsidiary Consumers Energy. Net-net: rate case overhang + leadership churn = need the Q2 call to confirm the data center narrative. Not a conviction name today but worth monitoring for the re-rate if they clear the cloud.
GS initiates Neutral, $205 PT. They like the long-term tower tailwinds (data consumption, densification, 6G buildout) but see a sloggy 18-month stretch before any organic growth re-acceleration materializes. Stock at $180.95 — that's a decent risk/reward if you're willing to sit through the noise, but not a catalyst-rich setup for PMs hunting near-term alpha.
"Domestic organic growth to bottom in 2026 at negative 3% before growing 3% in 2027."
That’s the core tension: DOMESTIC ORG GROWTH GOES NEGATIVE THIS YEAR, then a tepid bounce. International picks up from 1% to 4% in 2027 as legacy churn in Brazil fades. AFFO/share drops 3% in 2026 before returning to 6% growth next year. GS flags carrier consolidation churn, Echostar disruptions, and elevated debt refinancing costs as the near-term sludge. Not a broken story — just one that needs time to clear the pipes.
Waymo’s supply-constrained transition is the story. Citizens re-ups Market Outperform / $100 PT (stock at $72.25, 29% below the 52-week high). The bull case rests on autonomous miles still growing 134% YoY, but the 1Q26 deceleration (14% QoQ vs 40% prior quarter) is real — and it’s mechanical: Jaguar I-PACE inventory ran dry, and the Ojai only started public trips in May. That supply pinch diluted existing market miles as new cities like Atlanta and Houston ramped.
The base case: Waymo miles are “likely understated” while supply constraints persist. Once Ojai fleet scales, QoQ growth should re-accelerate. The broader Uber thesis — platform leverage, Eats retailer expansion (Kiehl’s, FedEx Office), Lime anchor investment — is secondary to AV positioning right now.
"The metrics are likely understated while new markets dilute supply from existing reported markets while Waymo remains supply constrained."
Bottom line: Near-term chop, but the 100 bogeys target implies 38% upside. You’re trading a 12-month option on Ojai supply relief and regulatory momentum. The delivery fee compression vs DoorDash (-1% vs +21%) is worth watching — not a crisis yet, but signals grocery margin pressure.
Neutral rating stays, but PT gets a big bump to CHF88 from CHF69. UBS is leaning into the electrification story — data center and utility orders remain strong, short-cycle supportive. They peg Q2 group growth at 7.6% orders / 10.8% revenue, right in line with consensus. The real delta is in Electrification: UBS estimates 25% growth vs consensus at 21% (down from 44% last quarter, so the comps are getting tougher but still solid). Automation is the weak spot — risk to consensus if no big surprise orders land, given high Q2 2025 comps.
"UBS expects a continuing strong orders environment for Electrification, driven by data centers and utilities and supported by short-cycle business."
No further major estimate upgrades expected — consensus already sits at 10.6% organic sales growth and ~100bps margin expansion. UBS’s group adj. EBITA margin estimate of 19.6% is a tick below consensus at 19.9%. The broader analyst backdrop is mixed: RBC raised PT on cash flow, Kepler downgraded to Hold on valuation. Net-net, the electrification theme is alive, but the r/r feels capped at these levels without a catalysts from Automation.
Goldman starts CCI at Neutral, $95 PT. That's 19% upside from $79.53, but the catalyst path is back-loaded. Near-term, the numbers are ugly: $220M of DISH churn hitting FY2026 FFO, plus carrier leasing is muted across the board. Long-term secular data demand, spectrum auctions and a 5.34% yield are the hooks, but the r/r hinges on whether the cost restructuring ($65M annual opex savings) can bridge the gap before AFFO growth re-accelerates. Not a home run setup, but the pure-play domestic tower angle with lowest peer risk profile gives it downside protection.
"Near-term fundamentals will be pressured by the removal of Echostar/DISH contracted revenue, which represents $220 million of churn in fiscal year 2026, and muted carrier leasing activity."
UBS stays Neutral at $235, but CHTR at $131 (3.5x P/E) is pricing in a death spiral. The Q2 setup looks horrid — revenue -2.4% and EBITDA -2.7%, both worse than Street. The only real game in town is the buyback: $4B projected (22% of market cap), $1B already done in Q2. At 6x forward EBITDA on UBS's target, there's theoretical upside if the narrative stabilizes. But the rate of change is still negative, and leverage post Cox/Liberty deals is a live grenade.
"UBS models improvement in the second half of 2026, in line with prior management commentary, as elevated expenses are lapped, potential broadband price increases take effect and high-margin political advertising begins."
Bernstein SocGen echoes the caution with Market Perform, flagging leverage and liquidity. The bull case is purely a capital returns story — shrink float faster than EBITDA falls. The bear case is that cord-cutting terminal velocity is higher than anyone models, and 6x is not cheap if FCF keeps compressing. PMs should watch Q2 print for any sign the trough is real. Until then, this is a bet on management’s ability to cancel shares faster than they lose subscribers.
RBC upgrades AMT to Outperform — putting it on the podium as the firm’s top tower pick. PT goes to $205 from $195. Thesis: superior U.S. net organic growth vs peers through FY26, plus CoreSite gets a higher multiple (25x from 21x). Recent asset visits confirmed the bullish read.
AMT trading at $168.72, essentially hugging the 52-week low ($165.08). RBC thinks the sector’s LEO satellite scare + higher rate outlook have been overdone — sees the pullback as an opportune time for buybacks. (They’re not alone: Bernstein, Truist, and BofA all upgraded or raised PTs recently, though RBC is now loudest.)
The €750M note pricing and credit facility amendments get a mention — boring, but +ve for liquidity and maturity extension.
Bottom line: RBC is leaning into the organic growth story and a CoreSite re-rate. Risk? Rates stay high, LEO fears linger. But at these levels, the r/r skews favorable if you believe the organic growth trajectory holds.
Lake Street cuts INVE to Hold, PT slashed to $4 from $6 after the IoT asset sale to Trackonomy. The thesis: INVE pivots to compliance SaaS after selling its RFID hardware business (and contributing $25M in cash for $50M in preferred equity). That leaves the balance sheet thinner and the M&A path murkier. Q1 beat and ID-Pixels 3.0 announcement don't change the near-term calculus.
"Most investors will likely be underwhelmed as the company still needs to successfully complete acquisitions but is now doing so with a smaller cash balance."
Shares at $3.69, below the new target, and the analyst sees them range-bound near term. Not a lot to do here unless you're banking on a Trackonomy exit that materializes in years, not quarters.
SELL. Goldman Sachs downgraded China Telecom to Sell from Neutral with a revised PT of HK$4.20 (was HK$6.00). The ADR sits at $11.40, down 53% over the past year – a 61% collapse from its 52-week high. Q1 revenue dropped 3% YoY, net income fell 17% to Rmb7.4bn, and the firm sees 5G spending continuing to drag. The AI token service pivot (consumer Rmb9.9-49.9/mo, business Rmb39.9-299.9/mo) can't mask the structural revenue erosion.
"Goldman Sachs expects soft 5G spending to continue weighing on core business growth in the near term."
Limited upside here after the 266% run. GF Securities cut to Hold, and the logic is straightforward: the AI revenue re-rating to $70B+ is already in the price, and at 20x+ FY28 EPS (25x AI, 15x core) the risk/reward is uncompelling. Near-term support from GB300/HGX orders is real, but they’re flagging that Super Micro will eat into SpaceX next-gen deployment starting 2027 and both SpaceX and CoreWeave are evaluating ODM-direct. The market has already priced the AI uplift — so where’s the next catalyst?
"The firm sees limited upside amid elevated expectations." — Jeff Pu, GF Securities
(Also: DELL closed a $3B notes offering, a $1.4B USAF contract, and launched the PowerEdge XE8812 with Nvidia Vera Rubin. None of that changes the valuation math.)
NVDA — NVFP4 quantization for GLM-5.2 cuts HBM footprint ~69% vs BF16, dropping from 5 Blackwell GPUs to 3. Scale-mover for aggregate capex efficiency, but distribution risk for HBM vendors. Market will debate moat vs volume growth threat. Meanwhile, TSMC CoWoS+SoIC expanding at 80% CAGR through 2027 raises supply ceiling but memory remains the binding constraint. A100 secondary pricing up 20% while H100 spot down 40% — generational transition, not demand collapse.
AVGO — 'Jalapeño' ASIC with OpenAI is the headline, but TH6 switch delivery timing is the real variable for 1.6T optical. The '1.6T cut' narrative was a misread — 800G demand revised UP 45% adds $14B TAM, 1.6T unchanged. Market is misunderstanding supplier-level granularity, creating an expectation gap. Also: Google exploring 2.4T lightweight coherent modules at 3x+ ASP could drive 2027 estimates higher.
INTC — CTO floating CPU:GPU ratio inversion from 1:4 to 10:1 as agents become 'virtual human workers.' Non-consensus bull thesis, but Intel Foundry 3nm not selling out — fabless customers queue for TSMC. Without CoWoS-equivalent packaging, Intel's capacity is not fungible for AI accelerators. Narrative ahead of execution.
COHU — Back-end test demand rising sharply with next-gen AI packaging. At 95% die yield, a 20-die package has only ~36% chance of being fully functional. Thermal control and burn-in become critical as chip complexity escalates. This is a structural demand driver the market is not fully pricing.
AEHR — Revenue fell 43% YoY. SiC burn-in position strong but AI orders not converting. Caught between EV slowdown and AI packaging ramp. Transition taking longer than anticipated. Management may need to reset expectations if AI orders continue to disappoint.
SNDK — Stock up +4,822% over 1 year, yet trades at 11.5x forward earnings. Memory shortage characterized as permanent through 2028 by some analysts. Kioxia CEO signals capacity discipline — 'we don't want to upset the balance of supply and demand.' NAND cycle longevity debate: peak or still early?
MSFT — Copilot: 20M+ paid seats, +250% YoY paid seat additions, customers with 50K+ seats quadrupled. Every 10M seats at ~$30/user/month = ~$3.6B annualized revenue. MSFT owns enterprise workflow layer. Stock trading below 200-week MA and at lowest EV/EBIT since 2017 — value trap or opportunity? Watch Azure guidance next.
AMZN — AWS raised GPU compute prices 20% for EC2 Capacity Blocks, excluding Trainium. Confirms AI compute scarcity and AWS pricing power. Strategic move to drive adoption of Trainium — self-designed chip cost advantage 30-50% vs H100 starting 2026-2027. Hyperscaler consortium to force HBM prices down could further improve AWS margins.
GOOGL — $80B equity raise flagged as potential 'secular peak' marker. Issuing equity to fund capex signals internal cash flow cannot cover the build. Negative signal for capital returns. Also: Gemini co-lead Noam Shazeer joining OpenAI — talent flight. Government restrictions on GPT-5.6 could temporarily benefit Google if it maintains model access.
META — Designing behind-the-meter AI data centers without backup generators, dropping reliability from 'five nines' to 'two nines.' Eliminates ~$1M/MW in backup equipment cost. Major scale-mover for capex efficiency. Not ruling out becoming a cloud provider. At 17x forward earnings with revenue growing 33% YoY — valuation attractive, but SBC ~10% of revenue is a dilution concern.
ORCL — Down ~55% from September peak, worst week since 2001 dot-com bust. Negative FCF of ~$24B, debt pile $130B. Market interrogating AI financing model. OpenAI IPO delay directly questions Oracle's most important cloud customer's funding. Ground zero of the AI financing re-rating. Next catalyst: Q1 FY27 capex guidance months away.
NOW — Surging as OpenAI threat weakens. GPT-5.6 limited release and IPO delay reduce the risk of AI disrupting enterprise SaaS. Narrative-driven bounce — more about AI fatigue rotation than fundamental change. IT spending data needed to confirm sustainability.
CRM — Similar bounce to NOW — 14 consecutive days of decline before this short-covering relief rally. Fundamentals unchanged. Still faces long-term risk from AI-native sales tools. Einstein hasn't caught fire. Government slower model releases buy time.
SFTBY — Crashed -12% Friday, -13% Thursday. Pure victim of AI private-to-public re-pricing. Son's portfolio includes OpenAI, Anthropic, etc. Public market effectively shorting the private AI bubble through SoftBank. Leverage play on AI — high risk, high reward.
GME — Reportedly advancing proposed acquisition of eBay. Transformative if true — moves from video games to e-commerce marketplace. Strategic logic questionable. Strong cash but operational expertise lacking. High-risk transformation vs desperate move.
EBAY — May be acquired by GameStop. Surprising potential bid. Sluggish growth but the rumor creates optionality. GameStop's offer price and financing unknown. Change of control could be beneficial if it leads to more aggressive strategy.
NKE — KeyBanc downgraded to Sector Weight. Lowest price in 11+ years. Consumer spending concerns, inventory issues, competitive pressure from Hoka and On Running. Value trap or recovery play? Macro signals mixed — UMich improved but factory job cuts near crisis levels.
HOOD — BTIG initiated at Buy with $125 PT, seeing 20%+ annual asset growth over next decade. Benefiting from retail trading and crypto recovery. Competition from Schwab/Fidelity and regulatory risk (PFOF) remain. Bullish initiation from sell side is a positive signal.
FCEL — Jefferies upgraded to Buy with $24 PT on potential demand for fuel cells in AI data center power backup. Meta dropping backup generators could actually increase demand for fuel cells as primary power. But costs remain high ($103-$140/MWh for on-site gas). Speculative.
APP — Scotiabank reiterated Sector Outperform with $775 PT on self-serve platform launch. AXON AI engine is a competitive moat. Privacy changes and platform risks persist. Stock has run significantly — valuation high.
GTLB — Launched new Git backend for machine-scale agentic execution — claims 'millions of agent sessions reliably,' 50x faster, 1000x less network traffic. Developed under Anthropic partnership. Positions GitLab as infrastructure for AI coding agents. Key debate: will it capture value from shift to agentic coding?
Hearing that NVDA's NVFP4 quantization for GLM-5.2 is being pushed aggressively by NVIDIA's software team — this is a deliberate strategy to compress HBM demand and reduce dependency on memory suppliers. Early channel checks suggest hyperscalers are already re-architecting inference clusters around lower GPU counts.
Word is OpenAI's GPT-5.6 limited release is a government-imposed bottleneck — not a voluntary delay. US govt cited 'anti-distillation' security concerns for restricting API access to trusted partners. This could structurally slow the monetization cycle for frontier models.
Channel checks suggest Microsoft is aligning its commercial org to sell Anthropic models via Foundry, directly threatening OpenAI's dominance in Azure-native workloads. Microsoft hired Anthropic's head of infrastructure — this is a double-edged sword for OpenAI's relationship with Azure.
Hearing Meta's decision to drop backup generators is not a one-off — at least two other hyperscalers are evaluating similar 'two nines' reliability standards for training-only facilities. This would change the capex/GW math significantly across the industry.
Rumored that a consortium of hyperscalers (led by AMZN) is forming to collectively negotiate DRAM/HBM pricing — trying to break the memory pricing cycle. If confirmed, this would pressure HBM margins for vendors like MU and Samsung.
Word is the MLCC shortage for Q4 is structural — BB ratios at Murata and SEMCO have exceeded 1.0 for three consecutive months. This is not a one-time spike. Passive component shortages risk increasing ODM rack costs by 3-5% in 2H.
Hearing back-end test equipment orders are accelerating — COHU and Advantest seeing increased demand for thermal control and burn-in systems for multi-die AI packages. One channel source says COHU's order book has doubled in the last 60 days.
Unverified gossip that Google's $80B equity raise was triggered by an internal cash flow shortfall — not just capex funding. If true, this is a major negative signal for capital returns and free cash flow quality.
Word is the '1.6T cut' narrative for optical networking was a misinterpretation of 800G demand being revised up 45%. Multiple suppliers confirm 1.6T volumes unchanged. AVGO is the key beneficiary due to TH6 switch chip positioning.
Hearing that at least one neocloud (name redacted) is facing financing difficulties as higher interest rates make their lease-to-debt structure unattractive. This could be the first crack in the pure-play compute reseller model.
Rumored that Apple's 20% price hike across its lineup is not just memory inflation — they are preemptively pricing in trade tariff risk ahead of 2027. Memory cost inflation is the official line, but the market is skeptical.
Channel checks from China suggest etch localization is accelerating faster than deposition — import data shows etch down 18% YTD vs deposition up 3% YTD. This is a leading indicator for domestic substitution in advanced nodes.
Word is the CPU:GPU ratio inversion thesis for INTC is gaining traction among a small group of hedge funds. They argue that as AI agents become software-consuming 'virtual workers,' CPU cycles will dominate inference workloads. Intel CTO is actively promoting this internally.
Hearing that ON Semi's Synaptics acquisition is causing internal turmoil — some key engineers in ON's AI data center power group are considering exits. The street is worried about distraction from the core silicon carbide and power management push.
Rumored that SoftBank's Vision Fund is facing margin calls on some leveraged positions. The -12% day on SFTBY was driven by forced selling, not just fundamental re-rating. Son is scrambling to shore up liquidity.
Word is the local data center revolt is going bipartisan — towns in Texas AND California are simultaneously slamming brakes on zoning approvals. This reinforces grid queue delay as the binding constraint, not chip supply.
Hearing that at least one major enterprise software company (not NOW or CRM) is in advanced talks to acquire an AI agent startup at a distressed valuation — a sign that the 'AI destroys everything' narrative is fading and consolidation is beginning.
Channel checks suggest NAND pricing may be more volatile than DRAM in the next 12 months. Kioxia's discipline is real, but Chinese NAND producer YMTC is ramping aggressively, threatening the supply-demand balance.
Rumored that Google's Gemini co-lead Noam Shazeer leaving for OpenAI is part of a larger talent exodus. Google's AI team has lost 3-4 senior researchers in the last 60 days. Internal morale is deteriorating.
Word is the government restrictions on GPT-5.6 and Anthropic's Fable could create a temporary moat for Chinese AI labs like ZAI. If US frontier models are slow-walked, Chinese models could catch up and even lead in cost-per-token efficiency.